Stock Information
Theravance Biopharma Inc (TBPH)
Ticker Symbol: TBPH
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $880.53 mil
Piotroski score: 3
PE Ratio: 16.43
EPS (TTM): 1.01
Revenue (TTM): $2.02 M
Dividend Yield: N/A
ROE: 19.4%
Latest News
-
Zymeworks Completes Acquisition of Theravance Biopharma
Wed, Sep 23, 2026 8:01 PM
-
Zymeworks' Theravance Deal Is A Breath Of Fresh Cash Flow
Fri, Sep 18, 2026 3:42 PM
Key Financials
Financial data not available